{"id":49720,"date":"2022-10-18T00:01:47","date_gmt":"2022-10-17T22:01:47","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\/"},"modified":"2022-10-18T00:01:47","modified_gmt":"2022-10-17T22:01:47","slug":"catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\/","title":{"rendered":"Catalent, Inc. Announces First Quarter Fiscal Year 2023 Earnings Conference Webcast"},"content":{"rendered":"
\n

SOMERSET, N.J.–(BUSINESS WIRE)–Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, manufacturing and clinical supply solutions for drugs, biologics, cell and gene therapies, as well as consumer health products, today announced that it will release financial results for the first quarter of fiscal year 2023 ended September 30, 2022, before the market open on Tuesday, November 1, 2022. The Company\u2019s management will host a webcast to discuss the results at 8:15 a.m. ET on the same day.\n<\/p>\n

<\/a><\/p>\n

\nCatalent invites all interested parties to listen to the webcast, which will be accessible through Catalent\u2019s website at http:\/\/investor.catalent.com<\/a>.\n<\/p>\n

\nA supplemental slide presentation will also be available in the \u201cInvestors\u201d section of Catalent\u2019s website prior to the start of the webcast. The webcast replay, along with the supplemental slides, will be available for 90 days in the \u201cInvestors\u201d section at www.catalent.com<\/a>.\n<\/p>\n

\nAbout Catalent, Inc.<\/b>\n<\/p>\n

\nCatalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply around 80 billion doses of nearly 8,000 products annually. Catalent\u2019s expert workforce of approximately 19,000 includes more than 3,000 scientists and technicians. Headquartered in Somerset, New Jersey, the company generated nearly $5 billion in revenue in its 2022 fiscal year. For more information, visit www.catalent.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Contact:
\n
Paul Surdez, Catalent, Inc.
\n
(732) 537-6325
\n
investors@catalent.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SOMERSET, N.J.–(BUSINESS WIRE)–Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, manufacturing and clinical supply solutions for drugs, biologics, cell and gene therapies, as well as consumer health products, today announced that it will release financial results for the first quarter of fiscal year 2023 ended September 30, 2022, before the … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49720","6":"format-standard","7":"category-industry"},"yoast_head":"\nCatalent, Inc. Announces First Quarter Fiscal Year 2023 Earnings Conference Webcast - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Catalent, Inc. Announces First Quarter Fiscal Year 2023 Earnings Conference Webcast - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SOMERSET, N.J.–(BUSINESS WIRE)–Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, manufacturing and clinical supply solutions for drugs, biologics, cell and gene therapies, as well as consumer health products, today announced that it will release financial results for the first quarter of fiscal year 2023 ended September 30, 2022, before the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-17T22:01:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221017005902\/en\/772236\/21\/Catalent_CMYK.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Catalent, Inc. Announces First Quarter Fiscal Year 2023 Earnings Conference Webcast\",\"datePublished\":\"2022-10-17T22:01:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\\\/\"},\"wordCount\":294,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221017005902\\\/en\\\/772236\\\/21\\\/Catalent_CMYK.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\\\/\",\"name\":\"Catalent, Inc. Announces First Quarter Fiscal Year 2023 Earnings Conference Webcast - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221017005902\\\/en\\\/772236\\\/21\\\/Catalent_CMYK.jpg\",\"datePublished\":\"2022-10-17T22:01:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221017005902\\\/en\\\/772236\\\/21\\\/Catalent_CMYK.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221017005902\\\/en\\\/772236\\\/21\\\/Catalent_CMYK.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Catalent, Inc. Announces First Quarter Fiscal Year 2023 Earnings Conference Webcast\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Catalent, Inc. Announces First Quarter Fiscal Year 2023 Earnings Conference Webcast - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\/","og_locale":"en_US","og_type":"article","og_title":"Catalent, Inc. Announces First Quarter Fiscal Year 2023 Earnings Conference Webcast - Pharma Trend","og_description":"SOMERSET, N.J.–(BUSINESS WIRE)–Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, manufacturing and clinical supply solutions for drugs, biologics, cell and gene therapies, as well as consumer health products, today announced that it will release financial results for the first quarter of fiscal year 2023 ended September 30, 2022, before the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-17T22:01:47+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221017005902\/en\/772236\/21\/Catalent_CMYK.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Catalent, Inc. Announces First Quarter Fiscal Year 2023 Earnings Conference Webcast","datePublished":"2022-10-17T22:01:47+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\/"},"wordCount":294,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221017005902\/en\/772236\/21\/Catalent_CMYK.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\/","url":"https:\/\/pharma-trend.com\/en\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\/","name":"Catalent, Inc. Announces First Quarter Fiscal Year 2023 Earnings Conference Webcast - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221017005902\/en\/772236\/21\/Catalent_CMYK.jpg","datePublished":"2022-10-17T22:01:47+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221017005902\/en\/772236\/21\/Catalent_CMYK.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221017005902\/en\/772236\/21\/Catalent_CMYK.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/catalent-inc-announces-first-quarter-fiscal-year-2023-earnings-conference-webcast\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Catalent, Inc. Announces First Quarter Fiscal Year 2023 Earnings Conference Webcast"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49720","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49720"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49720\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49720"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49720"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49720"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}